1. Within your health trust how many patients are currently [within the past 6 months] being treated for Melanoma?

2. Of these Melanoma patients how many are being treated for stage IV (advanced or metastatic) melanoma?

3. Of these how many are being treated for (advanced or metastatic) melanoma with the following;
Ipilimumab (Yervoy) single agent
Ipilimumab (Yervoy) in combination
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)
vemurafenib (Zelboraf) single agent
vemurafenib (Zelboraf) in combination
dabrafenib (Taflinar)
trametinib (Mekinist)
dabrafenib AND trametinib
dacarbazine (DTIC)

4. How many patients are currently [within the past 6 months] being treated for Non Squamous Cell Lung Cancer with the following;
Afatinib (Giotrif)
Ceritinib (Zykadia)
Crizotinib (Xalkori)
Erlotinib (Tarceva)
Gefitinib (Iressa)
Pemetrexed (Alimta)
Nivolumab (Opdivo)
Pembrolizumab (Keytruda)

5. How many patients are currently [within the past 6 months] being treated for Renal Cell Carcinoma (RCC) with the following;
Interferon (Intron A)
Bevacizumab (Avastin)
Sunitinib (Sutent)
Pazopanib (Votrient)
Aldesleukin (IL-2, Proleukin or interleukin 2)
Sorafenib (Nexavar)
Everolimus (Afinitor)
Temsirolimus (Torisel)
Cabozantinib (Cometriq)

Download response Melanoma patients and treatments. 240317